遗传突变和急性髓性白血病中的白血病:有没有联系?
Andrea Corbingi1, Rossana Putzulu2, Giuseppina Massini2
1Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, L.go A.Gemelli, 8, 00168, Rome, Italy. andreacorbingi@gmail.com.
结合细胞减小治疗的白血病治疗对高白血细胞性急性髓性白血病 (AML) 有效,特别是在症状患者中. 这种方法通过管理高白细胞计数来改善结果.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
背景情况:
- 急性髓性白血病 (AML) 是成年人中最常见的急性白血病.
- 在诊断时,高达20%的AML患者出现高白细胞症 (WBC>100,000/μL).
- 治疗方案包括医疗支持,细胞减小治疗和白血病.
研究的目的:
- 为了调查白血病在超白血细胞性AML中的作用.
- 为了确定AML亚型,分子变化,白血静止症症状和临床结果之间的关联.
- 评估白血在治疗超白血细胞症中的疗效.
主要方法:
- 对41名患有超白细胞性AML的患者进行了回顾性分析,这些患者接受了白血化.
- AML形态亚型和分子标记与白血静止症症状的相关性.
- 对临床结果的评估,包括30天死亡率.
主要成果:
- 有症状的超白细胞性AML患者表现出更高的白血细胞计数,30天死亡率,M4-M5亚型和更多的白血手术的趋势.
- 由于样本规模小,没有特定的分子标志物与白血静止症症状有显著的关联.
- 趋势表明,NPM1-突变的AML在无症状患者中更常见.
结论:
- 结合细胞还原治疗的白血病化是一种协同有效的策略,用于高白血细胞性AML.
- 这种综合方法对症状患者尤其有益,因为他们面临更高的死亡率.
- 临床结果似乎独立于特定的克隆标记,尽管需要对更大的队列进行进一步研究.
更多相关视频
06:28Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis
Published on: November 10, 2023
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
相关概念视频
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Differentiation of Common Myeloid Progenitor Cells
